NCT00760825View on ClinicalTrials.gov

A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

August 31, 2013

Conditions
Vibrio Cholerae
Interventions
BIOLOGICAL

killed bivalent (O1 and O139)whole cell oral cholera vaccine

1.5 ml given twice orally, 14 days apart

Trial Locations (1)

632 002

Christian Medical College, Vellore

All Listed Sponsors
collaborator

Shantha Biotechnics Limited

INDUSTRY

collaborator

Christian Medical College, Vellore, India

OTHER

lead

International Vaccine Institute

OTHER

NCT00760825 - A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children | Biotech Hunter | Biotech Hunter